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the human genome is constantly attacked by endogenous and exogenous agents (ultraviolet light, 
xenobiotics, reactive oxygen species), which can induce chemical transformations leading to DnA 
lesions. to combat DnA damage, cells have developed several repair mechanisms; however, if the 
repair is defective, DnA lesions lead to permanent mutations. Single-cell gel electrophoresis (coMet 
assay) is a sensitive and well-established technique for quantifying DnA damage in individual cells. 
nevertheless, this tool lacks relationship with mutagenesis. therefore, to identify errors that give rise 
to mutations it would be convenient to test an alternative known procedure, such as next generation 
sequencing (nGS). thus, the present work aims to evaluate the photomutagenicity of neuroleptic drug 
chlorpromazine (cpZ), and its N-demethylated metabolites using coMet assay and to test nGS as 
an alternative method to assess photomutagenesis. in this context, upon exposure to UVA radiation, 
coMet assay reveals cpZ-photosensitized DnA damage partially repaired by cells. conversely with 
this result, metabolites demethylchlorpromazine (DMcpZ) and didemethylchlorpromazine (DDMcpZ) 
promote extensive DnA-photodamage, hardly repaired under the same conditions. parallel assessment 
of mutagenesis by nGS is consistent with these results with minor discrepancies for DDMcpZ. to our 
knowledge, this is the first example demonstrating the utility of NGS for evaluating drug-induced 
photomutagenicity.
The human genome is exposed to continuous attack by endogenous and exogenous genotoxic stresses (ultravi-
olet light, ionizing radiation, xenobiotics, reactive oxygen species, etc). These agents can induce chemical trans-
formations leading to the most common DNA lesions: base and sugar modifications, alkylation, single strand 
breaks (ssb) generated by oxidation, and spontaneous hydrolysis. In this context, cells have developed several 
DNA-repair pathways; however, if damaged DNA is not properly repaired, DNA lesions may lead to permanent 
mutations in the genetic code as a consequence of the change in the sequence of base pairs1–7. For detecting 
genotoxicity in single cells, a very versatile, sensitive and well-established technique is the single-cell gel electro-
phoresis or COMET assay8–11. This tool is based on an electrophoresis with DNA of lysed, agarose-embedded 
cells, also known as nucleoids, which upon fluorescent staining appear a comet-like image. Thus, the comet head 
is composed of intact DNA, while the tail consists of single-strand or double-strand DNA breaks. The relative 
amount of DNA migrating away from the head of the comet is directly proportional to the extent of DNA damage. 
However, this data indicates DNA alterations but it does not necessarily relate to mutagenesis. Thus, the lack of a 
close relationship between DNA migration in the COMET assay and mutagenesis may be explained because the 
former detects unrepaired DNA, while in the latter only the misrepaired errors are considered. Therefore, in order 
to identify errors that might give rise to mutations it would be convenient to test the potential of an alternative 
known platform such as next generation sequencing (NGS) or high-throughput sequencing12–15. These techniques 
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allow an accurate assessment of mutations provided that the gene area covered is large, and the sequencing is deep 
enough, and they are straightforward, can be easily standardized and, nowadays, are affordable.
It is well known that chlorpromazine (CPZ), a neuroleptic drug used in the treatment of schizophre-
nia, can induce photosensitivity reactions16,17. Moreover, during phase I of metabolism, CPZ undergoes 
mono-N-demethylation and di-N-demethylation in the side chain. In this context, we have previously reported 
that demethylation of CPZ leads to metabolites demethylchlorpromazine (DMCPZ) and didemethylchlorprom-
azine (DDMCPZ), which maintain identical chromophore to the parent drug (Fig. 1), does not result in a detox-
ification but leads to an even enhanced photogenotoxicity18.
With this background, the aim of the present work is to evaluate the photomutagenicity of CPZ and its 
N-demethylated metabolites by means of the COMET assay and to test the potential of NGS as an alternative and 
straightforward procedure to assess photomutagenesis.
Methods
chemicals and reagents. Chlorpromazine hydrochloride (CPZ) was provided by Sigma Aldrich (Madrid, 
Spain). Demethylchlorpromazine (DMCPZ) and didemethylchlorpromazine (DDMCPZ) were synthesized as 
previously reported18. Fetal bovine serum (FBS), Dulbecco’s Modified Eagle Medium (DMEM) and penicil-
lin-streptomycin were purchased from Invitrogen (Madrid, Spain). Trypsin and L-glutamine solutions were 
supplied by Cultek (Madrid, Spain). Phosphate buffer saline sterile solutions (0.01 M, pH 7.4) were prepared 
in ultrapure water obtained from a Milli-Q water purification system. For single cell electrophoresis (COMET) 
assay, the electrophoretic tank and lysis solution were provided by Trevigen (Gaithersburg, USA), low melting 
point agarose was provided by Pronadisa (Madrid, Spain), and the SYBR Gold was obtained from Invitrogen. All 
other reagents were of HPLC grade and used without additional purification.
Absorption spectral measurements. Ultraviolet absorption spectra of CPZ, DMCPZ and DDMCPZ 
were recorded on a Shimadzu UV-1800 UV/VIS spectrophotometer. Measurements were performed in PBS 
(10−5 M) using 1 cm quartz cells with 3.5 mL capacity at room temperature.
cell culture experiments. The human skin fibroblast cell line (FSK) was cultured in DMEM supple-
mented with 10% FBS, 4 mM L-glutamine and 1% penicillin/streptomycin. The cells were routinely maintained 
in exponential growth (weekly passages, 1:3 splitting ratio) in 75 cm2 plastic flasks in a humidified incubator at 
37 °C under a 5% CO2 atmosphere. The day of the experiments, cells were first trypsinized, resuspended in cold 
PBS and allowed to recover at 4 °C for 2 hours (trypsin detachment generates mild DNA damage in FSK cell 
line). Then, FSK cells were seeded in duplicate at 1.0 × 105 cell/well or 2.0 × 106 cell/well in 24 or 6 well-plate 
for COMET assay or photomutagenicity studies respectively, and incubated at 37 °C in a CO2 incubator (100% 
relative humidity and dark conditions) with 10 μM of CPZ, DMCPZ or DDMCPZ solutions for 30 minutes. After 
incubation, one plate was placed in the multi-lamp photoreactor to irradiate the cells whereas the other one was 
kept in a dark box as a negative control.
Both COMET assay and photomutagenicity studies included ketoprofen (KP, 10 μM) as positive control. Cells 
were pretreated with KP at 37 °C in a CO2 incubator (100% relative humidity and dark conditions) for 30 minutes 
before the irradiation step.
irradiation procedure. All irradiation experiments were carried out with a photoreactor LZC-4 fitted with 
six top and eight side-UVA lamps (λmax = 350 nm; Luzchem, Canada), which emit 94% UVA radiation and 2% 
UVB radiation. The plastic lid does not absorb beyond 310 nm, which contributes to the mitigation of the effect 
of UVB radiation over the cell cultures. The irradiance was determined using a calibrated power meter detector, 
resulting an irradiance of 7 mW/cm2.The irradiations were performed through the lid of the plates for five min-
utes in order to achieve a UVA dose equivalent to 2 J/cm2. The viability rate of treated cells after UVA irradia-
tion was higher than 85%, indicating the suitability of the UV dose to overcome false-positive results triggered by 
extensive DNA fragmentation promoted by cell death. To prevent cell cultures from unwanted overheating, plates 
were kept on ice during the irradiation step and the temperature was regulated by ventilation.
Figure 1. (a) Chemical structures of chlorpromazine (CPZ) and its N-demethylated metabolites 
demethylchlorpromazine (DMCPZ) and didemethylchlorpromazine (DDMCPZ). (b) UV absorption spectra of 
CPZ, DMCPZ, DDMCPZ in PBS at 10−5 M.
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evaluation of cellular photogenotoxicity by coMet assay. Irradiated and non-irradiated cell sus-
pensions (100 μL) were carefully mixed with 100 μL of 1% low melting point agarose, and the drops were loaded 
on Trevigen treated slides placed on ice until jellification (2 × 104 cells/gel). Then, slides were immediately sub-
jected to cell lysis by incubation overnight in cold lysis buffer (2.5 M NaCl, 0.1 M Na2EDTA, 0.01 M Tris, 1% 
Triton X-100) or maintained in DMEM medium at 37 °C for 3 h and 6 h, and then lysed, to promote intrinsic 
cellular DNA-repair mechanisms. Next day, all slides were placed in the electrophoretic tank, covered with cold 
alkaline buffer (0.2 M NaOH, 1 mM EDTA, pH ≥13) and left during 40 min for DNA unwinding. Afterwards, the 
electrophoresis was carried out at 21 V (1 V/cm) for 30 minutes at 4 °C. Once the electrophoresis ended, the slides 
were washed twice in PBS for 5 min. DNA was fixed by two subsequent incubations in 70% ethanol and 100% 
ethanol. DNA comets and tails were stained with SYBR Gold (1:10.000) for 30 min (λexc: 495 nm and λem: 537 nm). 
Finally, the slides were air-dried and kept in darkness until their visualization. Visualization of comet nucleoids 
and tails was carried out with a Leica DMI 4000B fluorescence microscope using the Fluorescein FITC filter. At 
least 5 pictures of each sample were taken in order to determine DNA damage. The percentage of DNA damage 
of each sample was calculated with the visual scoring of at least 100 DNA Comets using the following equation: 
[(Nclass 0 Comets × 0) + (Nclass 1 Comets × 1) + (Nclass 2 Comets × 2) + (Nclass 3 Comets × 3) + [(Nclass 4 
Comets × 4) + (Nclass 5 Comets × 5) + (NClass 6 Comets × 6)]/6, where class 0 comets indicate comets with no 
DNA damage and class 6 comets indicate comets with maximum DNA damage.
photomutagenicity studies. Irradiated and non-irradiated samples were centrifuged at 1500 rpm for 
5 min and cellular pellet was harvested and kept at −20 °C until DNA extraction. Thus, DNA extraction was 
carried out according to standard procedures, by using phenol/chloroform/isoamyl alcohol extraction and eth-
anol precipitation. The DNA was dissolved in sterile 100 mM Tris hydrochloric acid, pH 8.0, and 1 mM ethyl-
endiaminetetraacetic acid at a final concentration of 400 to 600 μg/mL, and stored at 4 °C in sterile plastic vials. 
Mutagenicity studies were carried out by means of targeted deep sequencing (Ion PGM Targeted Sequencing, Life 
Technologies). BRCA1 and BRCA2 were selected as the reporter genes based on the availability of straightforward 
and inexpensive analyses and because of the high bp coverage comprised in the analyses. The chromosomal 
regions analysed correspond to well-known genes related to breast cancer since more than two decades ago19,20. 
The analyses covered 24.830 bp, 167 amplicons and the mean coverage was always higher than 340 x. Quality 
control data for the sequencing analyses are summarized in Table 1.
Results and Discussion
As stated above, in the photogenotoxicity studies for CPZ, DMCPZ and DDMCPZ carried out with cellular DNA, 
COMET assay revealed that the metabolites were more photogenotoxic than CPZ itself18. Therefore, to assess 
whether the cells can repair DNA damage photosensitized by CPZ and its N-demethylated metabolites after sev-
eral hours, COMET assay of FSK cells treated with CPZ, DMCPZ or DDMCPZ was carried out after UVA light 
irradiation followed by 3 h or 6 h of cell recovery. Thus, the remaining DNA damage was calculated by using a 
classification of 6 DNA damage categories8.
As shown in Fig. 2 and Supplementary Fig. S1, DNA damage decreased with the time of recovery only for 
CPZ whereas the N-demethylated metabolites remained unchanged. Interestingly, for the parent drug CPZ it was 
observed a significant reduction in DNA damage following 6 h recovery. By contrast, for DMCPZ and DDMCPZ 
no substantial decrease of DNA damage was noticed after 6 h of cell recovery.
The gene areas sequenced contained several polymorphic regions and all polymorphisms identified were ana-
lyzed to assess mutagenicity. The gene locations on Assembly GRCh37 and identification numbers for the gene 
variations when available are shown in Table 2. Every irradiated sample (T = 5) was compared to a non-irradiated 
sample with identical composition of chlorpromazine or metabolites (T = 0). Mutagenesis was, therefore, assessed 
as the net difference between the percentage of the increase in heterogeneity for every variant at time = 5 versus 
time = 0 for the seven SNVs found in heterozygosity. Then, the average of all net differences in heterozygosity for 
all the SNVs mentioned above was used to assess the mutagenesis effect as shown in Fig. 3.
Our findings show that the extent of DNA changes as assessed with NGS was similar as that observed by the 
COMET assay, as shown in Fig. 3: Cells without treatment (FSK) showed negligible DNA changes, the effect of 
CPZ lower than that of DMCPZ and DDMCPZ and, finally, the effect of KP is low. A minor discrepancy, however, 
is observed with DDMCPZ, which seems to cause more DNA changes as assessed by NGS than that assessed with 








Coverage within the 
target region (%)
CPZ_T0 71217 10.2638 448.05 100
CPZ_T5 79209 11.3726 496.37 100
FSK_T0 57750 8.3150 363.15 100
FSK_T5 55302 7.8122 341.58 100
DMCPZ_T0 83100 12.0291 525.74 99.82
DMCPZ_T5 87788 12.5787 549.36 99.98
DDMCPZ_T0 88685 12.7070 541.75 100
DDMCPZ_T5 86673 12.4188 542.69 100
Table 1. Summary of the NGS quality control metrics in the samples studied.
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Figure 2. Alkaline single cell gel electrophoresis COMET assay of cells treated (10 µM) with CPZ, DMCPZ or 
DDMCPZ. Cells without treatment (FSK) or cells treated with S-Ketoprofen (KP) were used as negative and 
positive control, respectively. Cells were treated, incubated for 30 minutes at 37 °C and then left unexposed 
(Dark, ◼), irradiated at 2 J/cm2 dose (UVA Light, ◻) or irradiated at 2 J/cm2 dose followed by 3 h or 6 h of cell 
recovery: UVA Light + 3 h cell recovery, ◼ and UVA Light + 6 h cell recovery, ◼, respectively. The percentage of 
DNA damage was obtained for compounds tested by visual scoring. Data are the mean ± SD of 4 independent 
experiments. Asterisks denote significant differences relative to treated and irradiated FSK cells by means of the 











chr13:32907420 rs397507608 No — —
chr13:32907615 – Yes A/ATATCT 49.12 ± 3.36
chr13:32912299 rs543304 Yes C/T 51.65 ± 3.72
chr13:32912345 rs80359406 No — —
chr13:32913055 rs206075 yes C/T 49.42 ± 1.75
chr13:32915005 rs206076 Yes C/G 48.55 ± 2.47
chr13:32929387 rs169547 Yes C/T 48.21 ± 2.66
chr13:32944741 rs11571744 Yes C/T 48.24 ± 2.94
chr13:32954302 – No — —
chr13:32968808 – No — —
chr17:41244936 rs799917 Yes T/C 49.37 ± 2.56
chr17:41245586 – No — —
chr17:41276170 – No — —
Table 2. Gene variations analyzed. Chromosomal locations correspond to the Assembly GRCh37. Basal 
conditions represent non-irradiated and non-drug exposed cells.
Figure 3. Extent of mutagenesis assessed with NGS. Each bar shows the mean ± SE in the increase of 
heterogeneity (deviations from 50%) for all SNVs observed in heterozygosity in this study (Table 2). T-Test 
indicated statistically significant differences (p < 0.001) for all comparisons between irradiated drug-treated 
cells versus irradiated FSK-cells.
5Scientific RepoRtS |         (2020) 10:6879  | https://doi.org/10.1038/s41598-020-63651-y
www.nature.com/scientificreportswww.nature.com/scientificreports/
higher sensitivity or a higher discrimination capacity when a high level of DNA damage is achieved. Even with the 
minor discrepancy observed with DDMCPZ, the Pearson Correlation Coefficient (R value) for the comparison 
between the results obtained by NGS and the COMET assay is very high = 0.9530. Although additional comparative 
studies are required to prove whether NGS can be even more sensitive than the COMET assay, our findings confirm 
that NGS has potential for DNA damage assessment thus adding more uses to this powerful sequencing technique.
It should be stated that, because DNA is collected shortly after cell irradiation, the DNA changes observed by 
NGS are not fixed in the cell genome and, therefore, the presence of mutations in the NGS study does not mean 
that these mutations will be permanent. Permanent mutations cannot be detected after cell treatment with drug 
or its metabolites and irradiation, because this combination promotes cell death in FSK cells after 24 h assessed 
by trypan-blue exclusion assay (data not shown). Indeed, high cell viability is a requirement to avoid misleading 
results as cell death also promotes DNA fragmentation by activation of caspase-activated DNases (CADs). We 
analyzed DNA damage 3 h after cells were incubated with drug or metabolites followed by UVA irradiation, when 
cell viability is higher than 85%. Therefore, it may be argued that the mutations detected by means of NGS may 
result from an artifact of amplification of damaged DNA. However, this is unlikely because the total number of 
reads, bases and the coverage of the NGS experiments are similar in irradiated and non-irradiated cells (Table 1). 
Therefore, although the DNA changes detected by NGS are not permanent, they reflect DNA variation after irra-
diation. Another potential limitation is that our findings are based on the seven SNVs observed in heterozygosity 
in the cells, and that this procedure is limited as compared to other strategies such as classic shuttle vectors, or 
even specific genes sequenced individually after cloning in bacteria. However, NGS procedures have the advan-
tage of the speed of the process, and the correlation of the results obtained by NGS assessment and the COMET 
assay is, at least in this pilot study, very high.
In conclusion, the combination of the single cell gel electrophoresis (COMET) assay and next generation 
sequencing (NGS) has been successfully applied to assess the photomutagenicity of CPZ, a well-known neuro-
leptic drug, in comparison with its N-demethylated metabolites DMCPZ and DDMCPZ. Upon exposure to the 
UVB-UVA fraction of ultraviolet radiation contained in sunlight, the COMET assay reveals CPZ-photosensitized 
DNA damage that is partially repaired by cells after several hours. By contrast with this result, the metabolites 
DMCPZ and DDMCPZ mediate extensive DNA- photodamage, which is hardly repaired under the same condi-
tions. Parallel assessment of the extent of DNA changes by means of NGS are consistent with these observations, 
showing the same trend with minor discrepancies for DDMCPZ. To our knowledge, this is the first example 
demonstrating the utility of NGS for assessing drug-induced photomutagenicity. Further NGS studies in different 
comet DNA fractions separately, might refine the potential of NGS in photomutagenicity assessment.
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